|
Antidepressant
Medications No Longer Linked to Suicide Attempts
< Jul.
04, 2007 > -- Suicide attempts dropped among people with depression soon after they started treatment, either with antidepressant drugs or psychotherapy, a study of more than 109,000 patients shows.

The
study results come after a controversial 2004 recommendation
on antidepressant labeling from the US Food and Drug Administration (FDA).
That move required a strong "black box" warning
on the labeling of drugs called selective serotonin
reuptake inhibitors (SSRIs), which include CelexaTM, PaxilTM, ProzacTM, and ZoloftTM.
A
black box warning is a prominent medication-label alert for
high risk prescription drugs that may cause serious
injuries or death.
The warning outlined the potential for an increase in suicidal thoughts among teenagers and young adults who were prescribed the medications. The warning also urged closer clinical monitoring of these patients.
However, "the FDA warning
was based on placebo-controlled trials," notes lead researcher Dr. Greg Simon, a psychiatrist and researcher at Group Health, a Seattle-based nonprofit health care system. "They
did not look at suicide attempts, because they were
too rare. In the whole group of studies the FDA looked
at, there were only two suicide attempts," Dr. Simon
says.
The current trial, published in the American Journal of Psychiatry, does focus on suicide attempts. It finds that pharmaceutical and psychotherapy treatments aimed at fighting depression reduce those attempts.
Dr. Simon's study looked at suicide attempts among more than 70,000 people who got an antidepressant prescription from their primary care physicians, almost 7,300 people who got prescriptions from a psychiatrist, and more than 54,000 who started psychotherapy for the treatment of depression.
"The pattern of [suicide] attempts over time was the same in all three groups: highest in the month before starting treatment, next highest in the month after starting treatment, and declining thereafter," the
report says. This supports the fact that suicide attempts
often precipitate a referral for treatment.
"Results were unchanged after eliminating patients receiving overlapping treatment with medication and psychotherapy. Overall incidence of suicide attempts was higher in adolescents and young adults, but the time pattern was the same across all three treatments," according
to the researchers.
The overall incidence of suicide attempts in the first six months was highest in those taking antidepressant drugs prescribed by a psychiatrist (1,124 attempts per 100,000), lower among those starting psychotherapy (778 per 100,000) and lowest of all among those who were taking antidepressants prescribed by a general practitioner (301 per 100,000).
The lower attempt rates among those starting psychotherapy or seeing a general practitioner could be related to less severe illness.
"Our study indicates that there's nothing specific to antidepressant medications that would either make large populations of people with depression start trying to kill themselves - or protect them from suicidal thoughts," says Dr. Simon. "Instead,
we think that, on average, starting any type of treatment
- medications, psychotherapy, or both - helps most
people of any age have fewer symptoms of depression,
including thinking about suicide and attempting it."
Experts
agree that regularly monitoring patients during treatment
with antidepressants helps to ensure that they are
receiving the right medication at a dose that helps
them feel better. "If people feel agitated or suicidal, they should seek help from a doctor or therapist," according to Dr.
Simon.
Always consult your physician for more information.
|